"Chu Vision Institute is a leader in contemporary eye care services. Seeing patients throughout several communities of Southern Minneapolis, our skilled team, led by Dr. Ralph Chu, performs a range of treatments to address glaucoma, cataracts, keratoconus and other cornea-relates issues, and refractive errors that range from slight to severe (such as myopia, hyperopia, and presbyopia). Our Bloomington, MN facility is also a leader in laser vision correction, such as LASIK, SMILE, refractive lens exchange, and PRK. A few of our other most sought-after treatments include reading vision correction, cataract surgery (traditional and refractive), and various MIGS (minimally invasive glaucoma surgery)."

During the past decade, Chu Vision Institute conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 5 clinical trials were completed, i.e. on average, 45.5% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 4 clinical trials were completed. i.e. 133.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Chu Vision Institute" #1 sponsor was "ReVision Optics, Inc." with 2 trials, followed by "Refocus Group, Inc." with 2 trials sponsored, "Abbott Medical Optics" with 1 trials sponsored, "AcuFocus, Inc." with 1 trials sponsored and "Aerie Pharmaceuticals" with 1 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Chu Vision Institute" #1 collaborator was "Carl Zeiss Meditec Cataract Technology, Inc." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Chu Vision Institute" are "Presbyopia" (5 trials), "Cataract" (4 trials), "Cataract Extraction" (1 trials), "Corneal Ectasia" (1 trials) and "Corneal Edema" (1 trials). Many other conditions were trialed in "Chu Vision Institute" in a lesser frequency.

Most popular intervention types in "Chu Vision Institute" are "Device" (10 trials) and "Drug" (7 trials). Other intervention types were less common.

The name of intervention was led by "Raindrop Near Vision Inlay" (2 trials), "0.02% Betamethasone Sodium Phosphate" (1 trials), "0.04% Betamethasone Sodium Phosphate" (1 trials), "Control Group" (1 trials) and "IC-8 IOL Group" (1 trials). Other intervention names were less common.

The vast majority of trials in "Chu Vision Institute" are 15 trials for "All" genders.

Currently, there are NaN active trials in "Chu Vision Institute". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 8 completed trials in Chu Vision Institute, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Chu Vision Institute, 1 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 6 trials that are defined as “Not Applicable".